ANHX

gene
On this page

Summary

ANHX (anomalous homeobox, HGNC:40024) is a protein-coding gene on chromosome 12q24.33, encoding Anomalous homeobox protein (E9PGG2).

Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of skeletal muscle cell proliferation; regulation of transcription by RNA polymerase II; and skeletal muscle fiber development. Predicted to be part of transcription regulator complex. Predicted to be active in nucleus.

Source: NCBI Gene 647589 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 68 total
  • MANE Select transcript: NM_001372060

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:40024
Approved symbolANHX
Nameanomalous homeobox
Location12q24.33
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000227059
Ensembl biotypeprotein_coding
Entrez647589

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 3 protein_coding

ENST00000419717, ENST00000545940, ENST00000673940

RefSeq mRNA: 2 — MANE Select: NM_001372060 NM_001191054, NM_001372060

CCDS: CCDS53855, CCDS91786

Canonical transcript exons

ENST00000545940 — 10 exons

ExonStartEnd
ENSE00001617662133226318133226438
ENSE00001622610133235807133235877
ENSE00001648442133218312133218971
ENSE00001653494133231517133231644
ENSE00001656095133226936133227152
ENSE00001674517133227824133227947
ENSE00001718184133219283133219367
ENSE00001734196133234108133234378
ENSE00003896409133225536133225828
ENSE00003897678133221205133221352

Expression profiles

Bgee: expression breadth broad, 50 present calls, max score 85.29.

Top tissues by expression

166 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099185.29gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047385.15gold quality
trabecular bone tissueUBERON:000248384.82silver quality
skeletal muscle tissue of biceps brachiiUBERON:000450284.53silver quality
spermCL:000001984.26silver quality
endothelial cellCL:000011584.04silver quality
mammary ductUBERON:000176583.98silver quality
myocardiumUBERON:000234983.75silver quality
gingival epitheliumUBERON:000194983.16silver quality
vena cavaUBERON:000408781.40silver quality
ventral tegmental areaUBERON:000269180.56silver quality
esophagus squamous epitheliumUBERON:000692080.09gold quality
heart right ventricleUBERON:000208079.81gold quality
cardia of stomachUBERON:000116279.05silver quality
inferior vagus X ganglionUBERON:000536379.04silver quality
dorsal plus ventral thalamusUBERON:000189778.69silver quality
lower lobe of lungUBERON:000894978.25silver quality
cerebellar vermisUBERON:000472078.22silver quality
cartilage tissueUBERON:000241878.21silver quality
pharyngeal mucosaUBERON:000035578.15silver quality
body of tongueUBERON:001187678.10silver quality
tongueUBERON:000172377.90silver quality
deciduaUBERON:000245077.90silver quality
lateral globus pallidusUBERON:000247677.79silver quality
deltoidUBERON:000147677.76silver quality
substantia nigra pars compactaUBERON:000196577.66silver quality
pericardiumUBERON:000240777.64silver quality
substantia nigra pars reticulataUBERON:000196677.63silver quality
lateral nuclear group of thalamusUBERON:000273677.57silver quality
superior vestibular nucleusUBERON:000722777.51silver quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.31

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

26 targeting ANHX, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4481100.0066.421669
HSA-MIR-34A-5P99.9971.211784
HSA-MIR-449A99.9971.051776
HSA-MIR-4745-5P99.9865.951028
HSA-MIR-34C-5P99.9770.451577
HSA-MIR-449B-5P99.9770.261580
HSA-MIR-6778-3P99.9667.292693
HSA-MIR-128-3P99.9571.172484
HSA-MIR-216A-3P99.9571.192505
HSA-MIR-3681-3P99.8870.462254
HSA-MIR-6739-5P99.8067.872806
HSA-MIR-6733-5P99.7467.942759
HSA-MIR-1249-5P99.6166.552049
HSA-MIR-6797-5P99.6166.552084
HSA-MIR-3160-5P99.2869.071938
HSA-MIR-4777-3P99.1568.92626
HSA-MIR-942-3P98.8169.04876
HSA-MIR-6728-3P98.6367.631534
HSA-MIR-59998.3266.991037
HSA-MIR-4684-5P98.2967.991650
HSA-MIR-10395-3P98.1066.701726
HSA-MIR-506-5P98.0267.411065
HSA-MIR-3144-5P97.6465.45646
HSA-MIR-194-3P97.3665.961027
HSA-MIR-59296.5967.59817
HSA-MIR-6767-5P90.0062.4197

Cross-species orthologs

8 orthologs

OrganismSymbolGene ID
danio_reriosix4aENSDARG00000004695
danio_reriosix4bENSDARG00000031983
danio_reriosix7ENSDARG00000070107
drosophila_melanogasterOptixFBGN0025360
drosophila_melanogasterSix4FBGN0027364
caenorhabditis_elegansWBGENE00000453
caenorhabditis_elegansWBGENE00000455
caenorhabditis_elegansWBGENE00006775

Paralogs (6): SIX4 (ENSG00000100625), SIX1 (ENSG00000126778), SIX3 (ENSG00000138083), SIX2 (ENSG00000170577), SIX5 (ENSG00000177045), SIX6 (ENSG00000184302)

Protein

Protein identifiers

Anomalous homeobox proteinE9PGG2 (reviewed: E9PGG2)

All UniProt accessions (3): E9PGG2, A0A669KBG6, A0A6E1YDD0

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Nucleus.

RefSeq proteins (2): NP_001177983, NP_001358989* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001356HDDomain
IPR008422KN_HDDomain
IPR009057Homeodomain-like_sfHomologous_superfamily
IPR017970Homeobox_CSConserved_site
IPR031701SIX1_SDDomain

Pfam: PF05920, PF16878

UniProt features (7 total): sequence conflict 3, chain 1, DNA-binding region 1, region of interest 1, compositionally biased region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-E9PGG2-F168.300.45

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 15 (showing top): GOCC_TRANSCRIPTION_REGULATOR_COMPLEX, chr12q24, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, SRC_UP.V1_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, MIR6728_3P, MIR506_5P, MIR599, GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_UP, GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY, GOMF_CIS_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING, PULVER_FOREY_PERTURB_ACCUMULATION_G1_S, PULVER_FOREY_PERTURB_ATTRITION_S, GOMF_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING, GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_DN

GO Biological Process (4): regulation of transcription by RNA polymerase II (GO:0006357), regulation of skeletal muscle cell proliferation (GO:0014857), skeletal muscle fiber development (GO:0048741), regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (3): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA binding (GO:0003677)

GO Cellular Component (2): nucleus (GO:0005634), transcription regulator complex (GO:0005667)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
RNA polymerase II transcription regulatory region sequence-specific DNA binding2
regulation of DNA-templated transcription1
transcription by RNA polymerase II1
skeletal muscle cell proliferation1
regulation of cell population proliferation1
skeletal muscle tissue development1
myotube cell development1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
cis-regulatory region sequence-specific DNA binding1
chromatin1
DNA-binding transcription factor activity1
regulation of transcription by RNA polymerase II1
nucleic acid binding1
intracellular membrane-bounded organelle1
protein-containing complex1

Protein interactions and networks

STRING

374 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ANHXNANOGNBQ7Z5D8645
ANHXLRRC71Q8N4P6567
ANHXARGFXA6NJG6535
ANHXLEUTXA8MZ59531
ANHXDUXBA0A1W2PPF3513
ANHXTPRX1Q8N7U7463
ANHXLYPD6BQ8NI32453
ANHXDUXAA6NLW8433
ANHXZNF415Q09FC8419
ANHXCLK4Q9HAZ1418
ANHXDPRXA6NFQ7405
ANHXHOXB1P14653384
ANHXDPPA3Q6W0C5383
ANHXGDF3Q9NR23381
ANHXIRX1P78414379

IntAct

0 interactions, top by confidence:

BioGRID (1): IGF2R (Cross-Linking-MS (XL-MS))

ESM2 similar proteins: A0A0J9YX94, A0A0J9YXQ4, A0A0J9YY54, A0A494C1R9, A5D7L8, A6NDY0, A6NKD2, A7E321, E9PGG2, F6SZT2, O14771, O19110, O75807, O88852, P0CV98, P0CV99, P0CW00, P0CW01, P0CW24, P17564, P78358, Q01534, Q0P5N2, Q15735, Q2KI51, Q2M329, Q587J8, Q5DTT8, Q5R5G8, Q5R6R8, Q5SV97, Q60465, Q62881, Q69ZB3, Q6P752, Q86V59, Q8BSI6, Q8IWY8, Q8N3D4, Q8VD63

Diamond homologs: E9PGG2, O42406, O93307, O95343, O95475, Q62233, Q94165, Q95RW8, Q9QZ28, A1YER0, A2D5H2, A6NDR6, A8K0S8, B3DM47, B4F6V6, O00470, O14770, O17894, O35317, O35984, O46339, O73916, P10842, P40424, P40425, P40426, P40427, P41778, P41779, P48731, P56661, P56662, P56666, P56667, P56668, P70178, P79937, P97367, P97368, Q15475

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

68 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance59
Likely benign7
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

1934 predictions. Top by Δscore:

VariantEffectΔscore
12:133225666:CAG:Cacceptor_gain1.0000
12:133225668:G:GCacceptor_gain1.0000
12:133226439:C:CCacceptor_gain1.0000
12:133234105:TACCT:Tdonor_loss1.0000
12:133234107:C:Adonor_loss1.0000
12:133234109:T:TAdonor_gain1.0000
12:133234375:CACT:Cacceptor_gain1.0000
12:133234377:CT:Cacceptor_gain1.0000
12:133234379:C:CCacceptor_gain1.0000
12:133225665:CCAG:Cacceptor_gain0.9900
12:133225667:A:Tacceptor_gain0.9900
12:133225668:G:Cacceptor_gain0.9900
12:133226435:TCCT:Tacceptor_gain0.9900
12:133226436:CCTC:Cacceptor_gain0.9900
12:133226437:CT:Cacceptor_gain0.9900
12:133227822:AC:Adonor_gain0.9900
12:133227823:CC:Cdonor_gain0.9900
12:133227823:CCCT:Cdonor_gain0.9900
12:133234106:A:ACdonor_gain0.9900
12:133234106:ACCT:Adonor_gain0.9900
12:133234107:C:CCdonor_gain0.9900
12:133234107:CCT:Cdonor_gain0.9900
12:133234107:CCTC:Cdonor_gain0.9900
12:133234374:CCACT:Cacceptor_gain0.9900
12:133234375:CACTC:Cacceptor_gain0.9900
12:133234376:ACT:Aacceptor_gain0.9900
12:133234376:ACTC:Aacceptor_loss0.9900
12:133234377:CTC:Cacceptor_gain0.9900
12:133234378:TC:Tacceptor_loss0.9900
12:133234378:TCT:Tacceptor_gain0.9900

AlphaMissense

3135 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
12:133227099:A:CF185L0.998
12:133227099:A:TF185L0.998
12:133227101:A:GF185L0.998
12:133231531:G:CF121L0.998
12:133231531:G:TF121L0.998
12:133231533:A:GF121L0.998
12:133227100:A:GF185S0.995
12:133231522:C:AR124S0.995
12:133231522:C:GR124S0.995
12:133231602:A:GW98R0.993
12:133231602:A:TW98R0.993
12:133227104:A:GW184R0.992
12:133227104:A:TW184R0.992
12:133227093:A:CN187K0.991
12:133227093:A:TN187K0.991
12:133227145:A:GL170S0.991
12:133231523:C:GR124T0.991
12:133231600:C:AW98C0.991
12:133231600:C:GW98C0.991
12:133227863:G:CF154L0.990
12:133227863:G:TF154L0.990
12:133227865:A:GF154L0.990
12:133231532:A:GF121S0.990
12:133227100:A:CF185C0.989
12:133231523:C:AR124M0.989
12:133231532:A:CF121C0.989
12:133231601:C:GW98S0.988
12:133227086:G:TR190S0.987
12:133227088:C:GR189P0.987
12:133227102:C:AW184C0.987

dbSNP variants (sampled 300 via entrez): RS1000065447 (12:133221497 G>C), RS1000118965 (12:133234316 G>A,C), RS1000137567 (12:133231618 C>T), RS1000154001 (12:133236441 T>C), RS1000276879 (12:133236649 G>A), RS1000349299 (12:133232107 T>A), RS1000365693 (12:133226169 G>C), RS1000580189 (12:133237370 A>G), RS1000859601 (12:133228065 A>G,T), RS1000892086 (12:133228349 G>A), RS1000932213 (12:133222560 C>T), RS1000961820 (12:133222518 C>A), RS1001046139 (12:133218152 C>CACACTGGAA), RS1001048200 (12:133218277 G>A), RS1001268018 (12:133222778 A>T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST010002_179Refractive error1.000000e-12
GCST010396_116Gut microbiota (bacterial taxa, hurdle binary method)7.000000e-07

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0007874gut microbiome measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.